Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Aspirin 'cuts prostate cancer risk'

  • Comment

A regular dose of aspirin can cut the risk of prostate cancer by almost a third, a report has claimed.

US researchers writing in the American Journal of Epidemiology found a 29% reduced chance of being diagnosed among men who took a low-strength dose of the medication every day. Long-term use was associated with a 24% decline.

While some scientists believe the results support the theory that inflammation plays an important role in the disease, other anti-inflammatory drugs such as ibuprofen had no effect.

Study leader Dr Janet Stanford, of the Fred Hutchinson Cancer Research Center in Seattle, Washington, said:

“The significant inverse association between prostate cancer risk and use of aspirin that we observed provides additional support for the role of inflammation in the development of this cancer.

“Aspirin is a widely used and inexpensive medication, and the potential public health implications of an effective chemopreventive agent for prostate cancer are considerable.”

Around 35,000 men are diagnosed with prostate cancer each year in the UK. Some 10,000 are killed by the disease.

Click here to view the article in the American Journal of Epidemiology

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs